Currently out of the existing stock ratings of Jonathan Block, 90 are a HOLD (31.8%), 189 are a BUY (66.78%), 4 are a SELL (1.41%).

Jonathan Block

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Block, currently employed at STIFEL, carries an average stock price target met ratio of 58.69% that have a potential upside of 33.49% achieved within 162 days.

Jonathan Block’s has documented 514 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on RMD, ResMed at 18-Dec-2025.

Wall Street Analyst Jonathan Block

Analyst best performing recommendations are on SKIN (BEAUTY HEALTH CO).
The best stock recommendation documented was for TRUP (TRUPANION) at 1/8/2020. The price target of $32 was fulfilled within 2 days with a profit of $5.08 (13.7%) receiving and performance score of 68.5.

Average potential price target upside

of $53.54 (23.33%) on ALGN (ALIGN TECHNOLOGY).
of $37.67 (13.25%) on IDXX (IDEXX LABORATORIES).
of $34.51 (29.72%) on INSP (INSPIRE MEDICAL SYSTEMS).

ALGN Align Technology COO The Cooper Companies Common Stock CVET Covetrus GKOS Glaukos Corp IDXX IDEXX Laboratories IIN IntriCon INSP Inspire Medical Systems NVST Envista Holdings Corp SDC SmileDirectClub SIEN Sientra SONX Sonendo TRUP Trupanion VERO Venus Concept XRAY Dentsply Sirona ZTS Zoetis ELAN Elanco Animal Health HOLX Hologic HSIC Henry Schein PDCO Patterson Companies SKIN Beauty Health Co NYXH Nyxoah CUTR Cutera KIN Kindred Biosciences VIVE Viveve Medical ARQT Arcutis Biotherapeutics SF Stifel Financial RMD ResMed

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score